Commodore Capital LP Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$1.6T
Holdings
36
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (36 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 3,350,000 | $167.4B | 10.46% | |
| 2 | VERAVERA THERAPEUTICS INC | 2,475,000 | $109.4B | 6.84% | |
| 3 | XENEXENON PHARMACEUTICALS INC | 2,700,000 | $106.3B | 6.64% | |
| 4 | PCVXVAXCYTE INC | 920,000 | $105.1B | 6.57% | |
| 5 | ELVNENLIVEN THERAPEUTICS INC | 4,100,000 | $104.7B | 6.54% | |
| 6 | NUVLNUVALENT INC | 940,000 | $96.2B | 6.01% | |
| 7 | COGTCOGENT BIOSCIENCES INC | 7,539,930 | $81.4B | 5.09% | |
| 8 | ALKSALKERMES PLC | 2,900,000 | $81.2B | 5.07% | |
| 9 | SLNOSOLENO THERAPEUTICS INC | 1,260,000 | $63.6B | 3.98% | |
| 10 | SYRESPYRE THERAPEUTICS INC | 1,988,084 | $58.5B | 3.65% | |
| 11 | VRDNVIRIDIAN THERAPEUTICS INC | 2,550,124 | $58.0B | 3.63% | |
| 12 | TCE2CELLDEX THERAPEUTICS INC NEW | 1,618,937 | $55.0B | 3.44% | |
| 13 | BRD1EURMIND MEDICINE MINDMED INC | 8,000,000 | $45.5B | 2.84% | |
| 14 | CATXPERSPECTIVE THERAPEUTICS INC | 3,350,000 | $44.7B | 2.79% | |
| 15 | NRIXNURIX THERAPEUTICS INC | 1,650,000 | $37.1B | 2.32% | |
| 16 | PHVSPHARVARIS N V | 1,911,433 | $35.4B | 2.21% | |
| 17 | KURAKURA ONCOLOGY INC | 1,800,000 | $35.2B | 2.20% | |
| 18 | RYTMRHYTHM PHARMACEUTICALS INC | 650,000 | $34.1B | 2.13% | |
| 19 | ORKAORUKA THERAPEUTICS INC | 1,369,714 | $33.6B | 2.10% | |
| 20 | ARVNARVINAS INC | 1,200,000 | $29.6B | 1.85% | |
| 21 | CELCCELCUITY INC | 1,522,332 | $22.7B | 1.42% | |
| 22 | CNTACENTESSA PHARMACEUTICALS PLC | 1,350,000 | $21.6B | 1.35% | |
| 23 | NKTXNKARTA INC | 4,662,073 | $21.1B | 1.32% | |
| 24 | ORICORIC PHARMACEUTICALS INC | 2,000,000 | $20.5B | 1.28% | |
| 25 | CCCCC4 THERAPEUTICS INC | 3,410,384 | $19.4B | 1.21% | |
| 26 | THRDTHIRD HARMONIC BIO INC | 1,360,569 | $18.4B | 1.15% | |
| 27 | SNDXSYNDAX PHARMACEUTICALS INC | 885,000 | $17.0B | 1.06% | |
| 28 | APGEAPOGEE THERAPEUTICS INC | 290,000 | $17.0B | 1.06% | |
| 29 | ABVXABIVAX SA | 1,284,110 | $14.8B | 0.92% | |
| 30 | TILINSTIL BIO INC | 150,929 | $10.2B | 0.63% | |
| 31 | NGNENEUROGENE INC | 200,000 | $8.4B | 0.52% | |
| 32 | —PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7.5B | 0.47% | |
| 33 | HLXCHELIX ACQUISITION CORP II | 500,000 | $5.2B | 0.33% | |
| 34 | CABACABALETTA BIO INC | 1,100,000 | $5.2B | 0.32% | |
| 35 | VTGNVISTAGEN THERAPEUTICS INC | 1,575,000 | $4.7B | 0.30% | |
| 36 | AVTXAVALO THERAPEUTICS INC | 483,000 | $4.6B | 0.29% |